← FDA DRUG APPROVALS

FDA ANDA · ANDA065060

AMOXICILLIN

Sponsor: SUN PHARM INDS LTD

APPLICATION
ANDA065060
TYPE
ANDA
ORIGINAL APPROVAL
2000-11-29
LATEST ACTION
2008-06-30
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 200MG · TABLET, CHEWABLE · ORAL
AMOXICILLINDiscontinued
AMOXICILLIN 400MG · TABLET, CHEWABLE · ORAL

Approval history

2008-06-30Labeling · Supplement 11AP
2006-07-31Labeling · Supplement 9AP
2006-05-04Labeling · Supplement 8AP
2005-11-29Labeling · Supplement 6AP
2004-04-23Labeling · Supplement 1AP
2000-11-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →